financetom
Business
financetom
/
Business
/
L3Harris, Joby Aviation partner to develop military aircraft
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
L3Harris, Joby Aviation partner to develop military aircraft
Aug 1, 2025 6:07 AM

(Reuters) -Defense firm L3Harris Technologies is working with air taxi maker Joby Aviation to develop a vertical take-off and landing aircraft for defense applications, the companies said on Friday.

Flight testing for the new military-grade version of Joby's VTOL aircraft is planned for fall 2025, with operational demonstrations expected in 2026.

Joby's gas turbine hybrid VTOL aircraft is designed for low-altitude missions and offers both piloted and fully autonomous flying.

"The next-generation of vertical lift technology enables long-range, crewed-uncrewed teaming for a range of missions," said Jon Rambeau, president of Integrated Mission Systems at L3Harris.

Joby CEO JoeBen Bevirt said the company has been working with the Department of Defense over the past decade to develop aircraft with dual-purpose technologies, including a gas turbine hybrid powertrain for its current S4 aircraft platform.

The Joby S4 is an electric VTOL aircraft designed as an air taxi for urban air mobility, that can carry one pilot and four passengers.

(Reporting by Aatreyee Dasgupta in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lonza to buy biologics site from Roche in U.S. for $1.2 billion
Lonza to buy biologics site from Roche in U.S. for $1.2 billion
Mar 19, 2024
ZURICH (Reuters) -Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.30 million) to upgrade the facility and enhance capabilities at the site to accommodate the next generation of mammalian...
Lonza to buy biologics site from Roche in US for $1.2 bln
Lonza to buy biologics site from Roche in US for $1.2 bln
Mar 19, 2024
ZURICH, March 20 (Reuters) - Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.3 million) to upgrade the facility and enhance capabilities at the site to accommodate the next...
Oil retreats from multi-month highs, strong dollar dents demand
Oil retreats from multi-month highs, strong dollar dents demand
Mar 20, 2024
SINGAPORE (Reuters) -Oil prices edged lower on Wednesday, as a stronger dollar curbed investor appetite while traders took some money off the table after benchmarks rallied to multi-month highs in the previous session. Brent crude futures for May fell 28 cents, or 0.3%, to $87.10 a barrel by 0711 GMT. U.S. West Texas Intermediate futures for April delivery, which expire...
Gucci's steep sales decline throws spotlight on China
Gucci's steep sales decline throws spotlight on China
Mar 20, 2024
By Mimosa Spencer PARIS (Reuters) - Shares of Kering are expected to open down on Wednesday, after the company warned first quarter sales at its star label Gucci would drop by around 20% due to weakness in Asia. The warning underscores the challenge Kering faces as it seeks to reignite sales momentum at Gucci, which accounts for half of group...
Copyright 2023-2026 - www.financetom.com All Rights Reserved